Targeting Immune Cell Wiring in Ulcerative Colitis

Neurath M, Chiriac MT (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Immunity Elsevier

Book Volume: 51

Pages Range: 791-793

Journal Issue: 5

DOI: 10.1016/j.immuni.2019.10.011

Abstract

The cytokine TNF is thought to play a major role in the immunopathogenesis of ulcerative colitis, and anti-TNF antibodies are considered as cornerstones of clinical therapy. Two clinical trials published in The New England Journal of Medicine now challenge this paradigm and suggest new avenues for research. The cytokine TNF is thought to play a major role in the immunopathogenesis of ulcerative colitis, and anti-TNF antibodies are considered as cornerstones of clinical therapy. Two clinical trials published in The New England Journal of Medicine now challenge this paradigm and suggest new avenues for research.

Authors with CRIS profile

Markus Neurath Lehrstuhl für Innere Medizin I

Additional Organisation(s)

Interdisziplinäres Zentrum für Klinische Forschung

Related research project(s)

A078: Smurf2-dependent repression of type I IFN signalling in inflammatory bowel disease and mucosal healing Jan. 1, 2021 - Dec. 31, 2023

How to cite

APA:

Neurath, M., & Chiriac, M.T. (2019). Targeting Immune Cell Wiring in Ulcerative Colitis. Immunity, 51(5), 791-793. https://doi.org/10.1016/j.immuni.2019.10.011

MLA:

Neurath, Markus, and Mircea T. Chiriac. "Targeting Immune Cell Wiring in Ulcerative Colitis." Immunity 51.5 (2019): 791-793.

BibTeX: Download